Home| Journals | Statistics Online Expert | About Us | Contact Us

    About this Journal  | Table of Contents

[Abstract] [PDF] [HTML] [Linked References]

International Journal of Recent Trends in Science and Technology, ISSN 2277-2812 E-ISSN: 2249-8109

Volume 12, Issue 1, September 2014 pp 17-20

Research Article

Comparative study of glycosylated hemoglobin and lipid profile in gestational diabetic women and normal pregnant women

B. J. Pradeep Kumar1, Sudhir Modala2,Parimala P.3, Manisha Baghel4

1,4Assistant Professor, Department of Biochemistry, Rohilkhand Medical College, Bareilly, Uttar Pradesh, INDIA.

2Assistant Professor, Department of Physiology, Rohilkhand Medical College, Bareilly, Uttar Pradesh, INDIA.

3Assistant Professor, Department of Biochemistry, Osmania University, Hyderabad, Andhra Pradesh, INDIA.


Aim: Lipid profile and glycosylated hemoglobin level changes in gestational diabetes. The extent to which this alteration takes place is still not clearly documented. Materials and Methods: To add a clear answer to this question, lipid profile parameters, and glycosylated hemoglobin status were determined in patients with gestational diabetes mellitus and compared to healthy pregnant women (controls). Results: Fasting plasma glucose levels, plasma glucose levels 1 hour, and plasma glucose levels 2 hours after 75 gm oral glucose administration (oral glucose tolerance test) were significantly higher in patients with gestational diabetes as compared to controls. Glycosylated hemoglobin was significantly higher in gestational diabetes than in controls. It was observed that there was a significant increase in serum cholesterol and serum triglyceride level in cases with gestational diabetes when compared to healthy pregnant women. Conclusion: The results of our study suggest that abnormal glucose levels, glycosylated hemoglobin, serum cholesterol, and serum triglycerides play an important role in pathophysiology of gestational diabetes, and therefore, extensive studies are required. Early diagnosis of gestational diabetes will decrease adverse neonatal and maternal outcomes